Ugur Sahin, BioNTech CEO (Bernd von Jutrczenka/dpa via AP Images)

BioN­Tech ex­pects to be $18.6B rich­er af­ter this year as Covid boost­ers churn out more da­ta. But it won't change much

Pfiz­er un­veiled the rich­es that its Covid-19 vac­cine is show­er­ing on it­self and part­ners at BioN­Tech when it pegged 2021 sales at $33.5 bil­lion. If …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.